Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1531 studies found for:    "Acute lymphoblastic leukemia"
Show Display Options
Download search resultsDownload the search results for:
"Acute lymphoblastic leukemia" (1531 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Prednisolone;   Drug: Daunorubicin;   Drug: Vincristine;   Drug: L-Asparaginase;   Drug: Cyclophosphamide;   Drug: Methotrexate;   Drug: Cytosine Arabinoside
2 Completed Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: vincristine;   Drug: dexamethasone
3 Not yet recruiting D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Dasatinib;   Drug: Blinatumomab
4 Completed Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: asparaginase;   Drug: recombinant asparaginase
5 Completed Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Intervention:
6 Unknown  Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+
Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: Epratuzumab and 90Y-Epratuzumab
7 Unknown  Genomic Changes in Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Intervention:
8 Active, not recruiting Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008
Condition: Childhood Acute Lymphoblastic Leukemia
Interventions: Drug: PEG-L-asparaginase ind;   Drug: PEG-L-asparaginase cons;   Drug: E.coli L-asparaginase;   Drug: High-dose Methotrexate;   Drug: Low-dose Methotrexate;   Drug: Triple intrathecal therapy;   Radiation: Cranial irradiation;   Drug: Daunorubicin
9 Active, not recruiting Treatment of High Risk Adult Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Vincristine;   Drug: Daunorubicin;   Drug: Prednisone;   Drug: Mitoxantrone;   Drug: Cytosine Arabinoside;   Drug: Dexamethasone;   Drug: Methotrexate (MTX);   Drug: Cytarabine;   Drug: ASP;   Drug: Mercaptopurine;   Drug: Teniposide;   Drug: Hydrocortisone
10 Completed Allogeneic Stem Cell Transplantation (SCT) With Treosulfan, VP-16 and Cyclophosphamid for Patients With Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoblastic Leukemia
Intervention: Procedure: Hematopoietic stem cell transplantation
11 Unknown  Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Intervention:
12 Completed Treatment of Acute Lymphoblastic Leukemia in Children
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: prednisone;   Drug: dexamethasone;   Drug: doxorubicin;   Drug: E. coli asparaginase;   Drug: vincristine;   Drug: methotrexate;   Drug: Leucovorin;   Drug: Asparaginase;   Drug: cytarabine;   Drug: Methotrexate/Hydrocortisone
13 Completed LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Vincristine;   Drug: Daunorubicin;   Drug: Prednisone;   Drug: L-Asparaginase;   Drug: Mitoxantrone;   Drug: Cytosine Arabinoside;   Drug: Hydrocortisone;   Drug: Mercaptopurine;   Drug: Cyclophosphamide;   Drug: Dexamethasone
14 Active, not recruiting Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients
Condition: Acute Lymphoblastic Leukemia
Interventions: Procedure: Haplo-identical HSCT;   Drug: Chemotherapy
15 Completed Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007
Condition: Acute Lymphoblastic Leukemia
Intervention:
16 Recruiting Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Condition: Acute Lymphoblastic Leukaemia
Interventions: Drug: VP16;   Radiation: TBI;   Drug: Thiotepa;   Drug: Treosulfan;   Drug: Fludarabine;   Drug: Busulfan
17 Completed
Has Results
Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Cyclophosphamide (CTX);   Drug: Vincristine;   Drug: Doxorubicin;   Drug: Decadron;   Drug: G-CSF;   Drug: Methotrexate (MTX);   Drug: Ara-C;   Drug: Pegaspargase
18 Completed Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: GRASPA
19 Completed Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: imatinib;   Drug: cyclophosphamide;   Drug: daunorubicin;   Drug: vincristine;   Drug: prednisolone;   Drug: methotrexate;   Drug: cytarabine;   Drug: dexamethasone
20 Active, not recruiting A Study in Adults With Untreated Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: prednisone;   Drug: doxorubicin;   Drug: vincristine;   Drug: methotrexate;   Drug: asparaginase;   Drug: dexamethasone;   Radiation: cranial radiation;   Drug: leucovorin;   Drug: cytarabine;   Drug: hydrocortisone;   Drug: 6-mercaptopurine (6-MP);   Drug: e. coli L-asparaginase

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.